According to the Pan American Health Organization, in Latin America and the Caribbean, more than 1 billion doses of the vaccine against covid-19 have been applied, but only 35% of the total population has a complete plan.
Mexico City (apro). Since the introduction of the first vaccine against Covid-19, more than 1 billion doses have been administered to countries in Latin America. But only 35% possess a complete plan. This schedule is World Health Two, as recommended by WHO.
Canada, Chile, Uruguay, and Puerto Rico have all vaccinated more 70% of the population. However, over a dozen countries in the region and more than half the total population have not been vaccinated to at least 20%. These include the Bahamas and Grenada as well Guatemala, Honduras and Jamaica.
Haiti is a case in point, with less that 1% of the population having been immunized.
Pan American Health Organization Director Carissa F. Etienne announced Wednesday that she had reached an agreement to Sinovac and is currently in dialogue with other manufacturers in order to purchase additional covid-19 vaccinations for them. To supplement bilateral agreements, donors and doses through the COVAX system, countries in the region are invited to participate.
“We have reached an accord with Kexing, and we have started accepting orders that will deliver vaccines this year. We expect to sign a second agreement within the next few days in order to purchase vaccines that have been approved under the WHO emergency use list. In a briefing, he stated that there were 2021 other suppliers in 2016 or 2022.
Dr. Etienne stated that COVAX had received approximately 50 million doses, and nearly 14,000,000 doses of donated vaccines, from the Pan American Health Organization. He said, “We have the capacity to expand this support fast, so we urge countries to not delay donations because life is in danger.”
COVAX, a joint initiative of WHO, GAVI Vaccine Alliance (CEPI), and UNICEF, aims to ensure equitable distribution of covid-19 vaccination.
Etienne also called on the region to increase its production capacity “to ensure a sustainable and reliable supply” of vaccines.
He highlighted the progress made by the Pan American Health Organization in accelerating the development and production mRNA vaccines.
Last week, the Pan American Health Organization announced that two centers were selected in Argentina and Brazil to develop a vaccine to combat covid-19. They are using the same technology and methods as Moderna and Pfizer.
“This is a strategic decision because mRNA can also be used in developing other viral vaccines for related public health issues within our region, such Zika virus, Dengue fever, and other viruses.” he stated.
PAHO invites both public and private pharmaceutical companies to develop and produce the basic components of mRNA vaccinations to join its regional platform.
Officials from the Pan American Health Organization pointed out that nearly 1.5 million cases of COVID-19 were reported in Americas and that the disease was responsible for more than 26,000 deaths. This is more than any other part of the world.
The number of deaths and infections in Canada is rising in North America. The number of infections and deaths in the United States decreased last week but increased.
Mexico also reported a decline in spread during the same time period.
However, many of the smaller islands in the Caribbean have seen an increase in their cases. Saint Lucia hospital reported a shortage and shortage of oxygen, as well as a rise in hospitalizations.